PHAR stock
Pharming Group NV (PHAR) valuation · rev $376.1M
Pharming Group NV (PHAR) rev $376.1M.
| Metric | Value |
|---|---|
| Market cap | $723.6M |
| Revenue | $376.1M |
| P/S | 1.9 |
PHAR valuation FAQ
What is PHAR's market cap?
Pharming Group NV (PHAR) market cap is $723.6M on the latest cached fundamentals snapshot.
What is PHAR's latest revenue?
Latest cached Pharming Group NV (PHAR) revenue was $376.1M. Statements: https://lician.com/financials/phar
What is PHAR's price-to-sales ratio?
Pharming Group NV (PHAR) price-to-sales (P/S) is 1.9, cached market cap $723.6M divided by revenue $376.1M.
How many PHAR valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Pharming Group NV (PHAR): Market cap, Revenue, and P/S.
Where is PHAR valuation listed?
Cached valuation multiples for Pharming Group NV (PHAR) are listed at https://lician.com/valuation/phar.
Not investment advice. Figures as filed or reported, not a live feed.